Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Endoscopic Eradication Therapy for Patients with Barrett’s Esophagus–Associated Dysplasia and Intramucosal Cancer

Publication Date: February 1, 2018

Last Updated: March 14, 2022

Recommendations

1. In BE patients with LGD and HGD being considered for EET, we suggest confirmation of diagnosis by at least 1 expert GI pathologist or panel of pathologists compared with review by a single pathologist. (C, L)

620

Overview

Title

Endoscopic Eradication Therapy for Patients with Barrett’s Esophagus–Associated Dysplasia and Intramucosal Cancer

Endoscopic Eradication Therapy for Patients with Barrett’s Esophagus–Associated Dysplasia and Intramucosal Cancer

Recommendations

Overview

Title

Authoring Organization